Publication of List of Manufacturers Revoked from Licensing for the Manufacture of Therapeutic Goods - Multigate Medical Products Pty Ltd

Overview

The Therapeutic Goods Act 1989 was enacted to regulate the supply of therapeutic goods in Australia and to ensure the quality, safety, and efficacy of these products. The Act addresses the need for rigorous oversight and control of therapeutic goods, including medicines, medical devices, and blood products, to protect public health. This particular piece of legislation, as published in Gazette C2013G00125, pertains to the revocation of a licence to manufacture therapeutic goods. The revocation was issued by Bill Turner, acting as a delegate for the Secretary of the Department of Health and Ageing, through the Therapeutic Goods Administration, pursuant to section 41 of the Act. The revocation was made at the request of the manufacturer, Multigate Medical Products Pty Ltd, and the specific licence, originally numbered 36352 and later MI-25102004-LI-000064-1, has been officially revoked, impacting the company’s ability to manufacture therapeutic goods. This action underscores the importance of compliance and the regulatory framework's role in maintaining standards within the therapeutic goods industry.

Scope and Application

The Therapeutic Goods Act 1989 applies to a wide range of entities and individuals involved in the manufacture, supply, importation, and advertising of therapeutic goods in Australia. The Act imposes a licensing regime on manufacturers of therapeutic goods, requiring them to obtain and maintain a licence to ensure the safety and quality of the products they produce. The Act also applies to entities and individuals involved in the supply and importation of therapeutic goods, regulating these activities to ensure public health and safety. The scope of the Act extends across the entire Commonwealth, ensuring a uniform regulatory environment for therapeutic goods across Australia. The Act includes provisions for the revocation of manufacturing licences where there is evidence of non-compliance or other breaches of the licensing requirements. In this case, the Secretary of the Department of Health and Ageing has revoked the licence of Multigate Medical Products Pty Ltd, a manufacturer of therapeutic goods, following a request by the company itself. The Act provides for the revocation of licences through subordinate instruments, which allows for flexibility and responsiveness to changes in the therapeutic goods market. There are no stated exclusions or thresholds in the Act that limit its application to certain types of therapeutic goods or manufacturers, although certain goods may be subject to additional regulations under other legislation.

Key Provisions

The Therapeutic Goods Act 1989 provides a framework for the regulation of therapeutic goods in Australia. One of the key provisions of this Act is the ability to revoke a manufacturer's licence, as outlined in section 41(1)(d) (1). This section allows the Secretary, through the Therapeutic Goods Administration, to revoke a licence to manufacture therapeutic goods under certain circumstances. In this particular case, the Secretary has revoked the licence held by MULTIGATE MEDICAL PRODUCTS Pty LTD, with the original number 36352 and licence number MI-25102004-LI-000064-1, based at 11-17 Nelson Road, Yennora NSW 2161, at the request of the manufacturer. Under the Act, manufacturers of therapeutic goods must comply with a range of obligations and requirements, including maintaining appropriate manufacturing facilities, ensuring products meet quality and safety standards, and keeping records of their manufacturing processes (2). The revocation of a manufacturer's licence signifies a failure to meet these obligations and requirements, and indicates that the manufacturer no longer meets the standards set by the Therapeutic Goods Administration. Breaching the obligations and requirements set out in the Therapeutic Goods Act 1989 can have serious consequences. Offences under this Act may result in criminal penalties, including fines and imprisonment (3). In the case of a manufacturer whose licence has been revoked, this may also result in the inability to manufacture or supply therapeutic goods in Australia. Additionally, the revocation of a licence may have civil consequences for the manufacturer, including financial penalties and reputational damage (4). In summary, the Therapeutic Goods Act 1989 provides a framework for the regulation of therapeutic goods in Australia, including the ability to revoke a manufacturer's licence under certain circumstances. The Act imposes a range of obligations and requirements on manufacturers, and breaches of these obligations and requirements may result in criminal or civil penalties, including the revocation of a manufacturer's licence. The revocation of a licence signifies a failure to meet the standards set by the Therapeutic Goods Administration, and may have serious consequences for the manufacturer in terms of their ability to operate in the Australian market.